SCIENSUS PHARMA SERVICES LIMITED

Information

Name

Type

Company

Roles

Supplier

Company Size

Large

Company Number

Incorporation Date

Website

https://www.sciensus.com

Address

107 Station Street

Burton-On-Trent
DE14 1SZ
United Kingdom

Suppliers

Unlock the full supplier list, free!

Sign up to unlock the full list of suppliers associated with SCIENSUS PHARMA SERVICES LIMITED
Sign up free

Contracts awarded to SCIENSUS PHARMA SERVICES LIMITED

The contracts that SCIENSUS PHARMA SERVICES LIMITED have been awarded to supply. Click on the contract to view more detailed information and view the full details about the contract won.

Award

Published 1 month ago

Aseptically Manipulated or Terminally Sterile Medicinal Products Framework (Lot 5)

The supply of aseptically manipulated or terminally sterile products to NHS Trusts within the boundaries of the Peninsula Purchasing and Supply Alliance (PPSA). Products include national dose-banded cytotoxic and non-cytotoxic batch and patient specific medicines in ready-to-use infusion bags, pre-filled syringes & elastomeric devices. This procurement is being managed by the PPSA on behalf of the Royal Devon University Healthcare NHS Foundation Trust acting for itself and for Gloucestershire Hospitals NHS Trust, Great Western Hospitals NHS Foundation Trust, Royal Cornwall Hospitals NHS Trust, Salisbury NHS Foundation Trust, Somerset NHS Foundation Trust, Torbay & South Devon NHS Foundation Trust, University Hospitals Plymouth NHS Trust, North Bristol NHS Trust, University Hospitals Bristol & Weston NHS Foundation Trust and the Royal United Hospital Bath NHS Foundation Trust.

£80,000,000
Award

Published 4 months ago

YHPPC Pharmacy-Homecare Low/Mid Tech HC Medicines Services

Framework Agreement for Low and Mid Tech Homecare Medicines Services. Will include service Lots to cover dispense, delivery and clinical services.

£26,000,000 Bids close: 10 months ago
Award

Published 4 months ago

NEYPPC Pharmacy-Homecare Low/Mid Tech HC Medicines Services

Framework Agreement for Low and Mid Tech Homecare Medicines Services. Will include service Lots to cover dispense, delivery and clinical services.

£234,000,000
Award

Published 4 months ago

NHS National framework agreement - Home Delivery Service Pulmonary Hypertension

NHS National framework agreement - Home Delivery Service Pulmonary Hypertension Offer reference number: CM/MSR/17/5557 Period of framework agreement: 1 June 2024 to 31 May 2026 with option(s) to extend for up to a total period of 24 months.

£15,665,120 Bids close: 10 months ago
Award

Published 4 months ago

NHS National framework agreement - Home Delivery Service Pulmonary Hypertension

NHS National framework agreement - Home Delivery Service Pulmonary Hypertension<br/>Offer reference number: CM/MSR/17/5557<br/>Period of framework agreement: 1 June 2024 to 31 May 2026 with option(s) to extend for up to a total period of 24 months.

£4
Award

Published 5 months ago

NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)

NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5) Tender Reference: CM/PHR/22/5686/01 Period of framework agreement: 1 April 2024 to 31 March 2028 (covering regions East of England, London, North of England and South East).

£608,000,000 Bids close: 9 months ago

Contacts

+44 3331039499

SCIENSUS PHARMA SERVICES LIMITED

Information

Name

Type

Roles

Company Size

Company Number

Incorporation Date

Website

Address

Suppliers

Contracts awarded to SCIENSUS PHARMA SERVICES LIMITED

Aseptically Manipulated or Terminally Sterile Medicinal Products Framework (Lot 5)

YHPPC Pharmacy-Homecare Low/Mid Tech HC Medicines Services

NEYPPC Pharmacy-Homecare Low/Mid Tech HC Medicines Services

NHS National framework agreement - Home Delivery Service Pulmonary Hypertension

NHS National framework agreement - Home Delivery Service Pulmonary Hypertension

NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)

Contacts

Statistics (1 Year)